Business in brief
THE REGION A closed-door federal meeting scheduled for today to discuss human testing of Biopure Corp.'s blood substitute was abruptly canceled yesterday after a growing outcry for the meeting to be opened to the public. Cambridge-based Biopure had hoped to launch a human trial of Hemopure , a blood substitute made from cows, which the Food and Drug Administration put ... (Full article: 653 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
